ScholarIQanswers from OpenAlex & ORCID
Michael J. Keating
ResearcherPublications, citations & collaboration network
Michael J. Keating is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael J. Keating have?
ScholarIQindexed works
Michael J. Keating has 1,756 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael J. Keating have?
ScholarIQcitation count
Michael J. Keating has 96,340 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael J. Keating?
ScholarIQh-index
Michael J. Keating has an h-index of 146 in OpenAlex.
What is the i10-index of Michael J. Keating?
ScholarIQi10-index
Michael J. Keating has an i10-index of 878 in OpenAlex.
What is the ORCID of Michael J. Keating?
ScholarIQorcid
The ORCID for Michael J. Keating is on the source record.
What is the OpenAlex record for Michael J. Keating?
ScholarIQopenalex
The OpenAlex for Michael J. Keating is on the source record.
What are the most-cited papers on Michael J. Keating?
ScholarIQmost cited works
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jörge E. Cortes, Susan Lerner, Michael J. Keating
Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia
William G. Wierda, Susan O’Brien, Sijin Wen, Stefan Faderl, Guillermo Garcia‐Manero, Deborah A. Thomas, Kim‐Anh Do, Jörge E. Cortes, Charles Koller, Miloslav Beran, Alessandra Ferrajoli, Francis J. Giles, Susan Lerner, Maher Albitar, Hagop M. Kantarjian, Michael J. Keating
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
Alessandra Ferrajoli, Bang-Ning Lee, Ellen Schlette, Susan O’Brien, Hui Gao, Sijin Wen, William G. Wierda, Zeev Estrov, Stefan Faderl, Evan N. Cohen, Changping Li, James M. Reuben, Michael J. Keating
Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation
Apostolia M. Tsimberidou, Susan O’Brien, Issa F. Khouri, Francis J. Giles, Hagop M. Kantarjian, Richard E. Champlin, Sijin Wen, Kim‐Anh Do, Susan Smith, Susan Lerner, Emil J. Freireich, Michael J. Keating